查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1939509

犬用葡萄糖胺補充劑市場按劑型、成分類型、配方和分銷管道分類，全球預測（2026-2032年）

Glucosamine Supplement for Dog Market by Form, Ingredient Type, Composition, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，犬用葡萄糖胺補充劑市場價值將達到 2.3644 億美元，到 2026 年將成長至 2.5755 億美元，到 2032 年將達到 3.8654 億美元，複合年成長率為 7.27%。

關鍵市場統計數據
基準年 2025 2.3644億美元
預計年份：2026年 2.5755億美元
預測年份 2032 3.8654億美元
複合年成長率 (%) 7.27%

一個實施框架，闡明了犬類關節健康領域產品創新、供應鏈韌性和不斷變化的寵物飼主期望之間的策略交集。

本導言為犬用葡萄糖胺補充劑領域的相關人員建立了策略背景，並闡述了為何如今採取以證據為基礎、目標明確的策略至關重要。該品類正處於寵物飼主期望不斷變化、配方科學不斷進步以及日益重視便利性和臨床可靠性的分銷環境的交匯點。因此，為了保持競爭力，企業必須將產品創新與供應鏈韌性、法規遵循度和差異化的市場推廣模式結合。

對推動犬類營養補充劑市場產品差異化、全通路分銷和供應鏈透明度的關鍵變化進行了深入分析。

犬用葡萄糖胺補充劑的市場環境正經歷著變革性的變化，這些變化正在重塑競爭格局，並影響著產品生命週期內的價值創造。首先，消費者的期望已不再局限於簡單的症狀緩解，而是轉向全面的關節健康解決方案，這推動了對多種配方、補充活性成分以及循證聲明的需求。這種轉變迫使品牌投資於臨床檢驗，並闡明能夠引起獸醫和專業寵物飼主共鳴的差異化價值提案。

對 2025 年關稅主導的貿易波動如何迫使供應鏈重組、價格調整以及價值鏈上的策略供應商多元化進行嚴格評估。

2025年美國關稅及相關貿易政策的累積影響波及整個犬類營養補充品價值鏈，促使企業對採購、定價和庫存管理策略進行策略性重新評估。進口關稅的提高和海關審查的加強推高了某些原料和包裝組件的到岸成本，擠壓了毛利率，迫使企業調整商業策略。為此，許多企業實施了產品組合最佳化，優先發展高利潤產品，推遲業績不佳的產品上市，同時也評估其他採購方案。

詳細的細分分析揭示了產品形式、成分化學、分銷管道趨勢、生命週期階段目標和配方如何決定商業性機會和營運重點。

細分市場洞察揭示了產品、通路和生命週期策略的交匯點，以及透過差異化創造永續競爭優勢的潛力。根據劑型，市場分析涵蓋咀嚼片、液體、粉末和片劑。咀嚼片又根據牛肉、雞肉和花生醬等熱門口味進一步細分，這些口味會影響寵物的偏好和復購率。劑型的選擇會影響生產複雜性、保存期限管理和產品宣稱，咀嚼片產品通常因其便利性和「零食般」的特性而享有高階定位。

全面的區域洞察：說明美洲、歐洲、中東和非洲以及亞太地區如何制定產品、分銷管道和監管策略，以支持全球擴張。

了解區域差異對國際成長至關重要，因為區域趨勢會顯著影響產品策略、通路選擇和監管規劃。在美洲，消費者需求偏向優質化和實證產品，線上和量販店通路滲透率很高。該地區通常強調便利性、口味多樣性和臨床可信度，並且往往是訂閱和會員忠誠度計劃的試驗場。跨境貿易流動和區域法規結構進一步影響產品配方選擇和標籤標註規範。

關鍵競爭情報重點分析配方科學、獸醫領導企業以及分銷管道執行如何使犬類關節保健品市場的領導者與追隨者區分開來

犬用葡萄糖胺市場的競爭動態主要圍繞著配方差異化、分銷管道覆蓋以及獸醫專業人士的信任度。主要企業採取不同的策略，一些企業強調以臨床試驗和獸醫推薦為支撐的高階複合配方，而另一些企業則以具成本效益、大批量、低成本的產品形式，針對大眾配銷通路進行競爭。品牌歷史和信任度也影響競爭定位，新參與企業則利用數位行銷和訂閱模式來推動產品試用。

為行業領導者提供切實可行的優先建議，幫助他們透過配方策略、數位化分銷、供應商韌性和增強監管信心來建立商業性優勢。

針對行業領導者的具體建議著重於使產品藍圖、商業模式和營運能力與當前市場實際情況相符。首先，應優先考慮兼顧證據、偏好和生產可行性的配方策略。整合互補活性成分的組合配方，若有清晰的作用機制證據和穩定性數據支持，則可確立高階市場定位。其次，應加速數位化優先分銷，同時與寵物專賣零售商和獸醫通路保持策略合作關係。應利用廠商直銷管道收集第一方數據，並檢驗訂閱和個人化方案；同時，應利用第三方市場平台擴大品牌知名度並降低獲客成本。

對支撐本分析的混合方法研究（結合一手訪談、產品審核、第二手資料分析和資料檢驗）進行清晰的解釋，以支援實際應用。

本分析的調查方法結合了定性和定量技術，以確保得出嚴謹且可操作的結果。主要研究包括對供應鏈相關人員、配方科學家、採購主管、零售商和獸醫專業人士進行深度訪談，以獲取有關功效預期、通路經濟效益和供應商能力的第一手資訊。此外，還對產品和包裝進行了審核，評估了代表性SKU的配方聲明、口味組合和生產特性。

簡要概述強調了整合產品可靠性、彈性營運和全通路策略執行以實現持續價值的必要性。

總之，犬用葡萄糖胺補充劑市場正處於一個轉折點，產品科學、不斷發展的分銷管道和貿易動態正在融合，共同塑造競爭優勢。寵物飼主對產品功效、安全性和便利性的期望日益提高，能夠透過複雜的配方、臨床檢驗和透明的採購流程清晰展現差異化價值的公司將贏得消費者的忠誠。同時，將廠商直銷與精選零售商和獸醫夥伴關係結合的分銷策略，將最佳化客戶獲取和維繫的經濟效益。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 犬用葡萄糖胺補充劑市場按劑型分類

  • 咀嚼型
    • 牛肉風味
    • 雞
    • 花生醬
  • 液體類型
  • 粉末
  • 藥片

9. 犬用葡萄糖胺補充劑市場按成分類型分類

  • 鹽酸鹽
  • N-乙醯
  • 硫酸鹽

第10章 犬用葡萄糖胺補充劑市場（按成分分類）

  • 混合型
    • 軟骨素
    • 玻尿酸
    • MSM
  • 單件

第11章 犬用葡萄糖胺補充劑市場（按分銷管道分類）

  • 量販店
  • 線上
    • 製造商官方網站
    • 第三方市場
  • 寵物專賣店
  • 獸醫診所

第12章 犬用葡萄糖胺補充劑市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 犬用葡萄糖胺補充品市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國犬用葡萄糖胺補充劑市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國犬用葡萄糖胺補充劑市場

第16章：中國犬用葡萄糖胺補充劑市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ainsworth Pet Nutrition LLC
  • All Living Things, Inc.
  • Biovencer Healthcare Private Limited
  • Elanco Animal Health Incorporated
  • Nestle Purina PetCare Company
  • Nutramax Laboratories, Inc.
  • PetLab Co., Inc.
  • TSI Group Ltd.
  • VetIQ, LLC
  • VetriScience Laboratories, Inc.
  • VetsPlus USA, Inc.
  • Zesty Paws IP, LLC
Product Code: MRR-9A6A6F2977E7

The Glucosamine Supplement for Dog Market was valued at USD 236.44 million in 2025 and is projected to grow to USD 257.55 million in 2026, with a CAGR of 7.27%, reaching USD 386.54 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 236.44 million
Estimated Year [2026] USD 257.55 million
Forecast Year [2032] USD 386.54 million
CAGR (%) 7.27%

Introductory framing that clarifies the strategic intersection of product innovation, supply chain resilience, and evolving pet owner expectations in the canine joint health arena

This introduction establishes the strategic context for stakeholders operating in the canine glucosamine supplement space and explains why a focused, evidence-driven approach is essential today. The category sits at the intersection of evolving pet owner expectations, advances in formulation science, and a distribution landscape that increasingly privileges convenience and clinical credibility. Consequently, companies must reconcile product innovation with supply chain resilience, regulatory compliance, and differentiated go-to-market models to remain competitive.

Pet owners are treating companion animals as family members, which has altered purchasing behaviours and elevated demand for premium, science-backed supplements. At the same time, ingredient innovation-such as variations in glucosamine forms and complementary agents-has expanded the formulation toolkit, enabling targeted positioning for life-stage, palatability, and combined therapeutic benefits. Against this backdrop, manufacturers and distributors are pressed to demonstrate both efficacy and safety through transparent labeling, third-party testing, and partnerships with veterinary professionals.

Moreover, the operational environment is becoming more complex as trade policies, logistics constraints, and channel economics shift. In response, successful players are prioritizing agility in procurement, digital-first consumer engagement, and data-driven segmentation to deliver tailored offerings. This introduction therefore sets up an imperative: firms must integrate product science, channel strategy, and supply chain tactics to seize growth opportunities while managing emerging risks.

Compelling analysis of the pivotal shifts driving product differentiation, omnichannel distribution, and supply chain transparency in the canine supplement market

The landscape for canine glucosamine supplements is undergoing transformative shifts that are reshaping competitive dynamics and value creation across the product lifecycle. First, consumer expectations have matured beyond simple symptom relief toward holistic joint health solutions, which is driving demand for combination compositions, adjunctive actives, and evidence-oriented claims. This evolution forces brands to invest in clinical validation and to articulate differentiated value propositions that resonate with veterinarians and discerning pet owners alike.

Second, distribution has shifted meaningfully toward omnichannel models where digital touchpoints substantially influence discovery and repeat purchase. While traditional mass merchants and pet specialty stores retain importance, online channels-both brand-owned and third-party marketplaces-are now central to customer acquisition and subscription models. Consequently, firms that integrate digital analytics with commerce functions gain faster insight into lifetime value and product performance across cohorts.

Third, ingredient sourcing and formulation choices are being re-assessed in light of logistical pressures and regulatory scrutiny. Manufacturers are experimenting with alternative glucosamine salts and complementary ingredients to optimize bioavailability, palatability, and manufacturing robustness. Finally, stakeholder expectations around sustainability, traceability, and responsible marketing are rising, requiring transparent supply chains, clean-label claims, and credible third-party certifications. Together, these shifts mandate cross-functional strategies that align R&D, manufacturing, regulatory affairs, and commercial teams to deliver differentiated, trusted products at scale.

Rigorous assessment of how tariff-driven trade shifts in 2025 forced supply chain reconfiguration, pricing realignment, and strategic supplier diversification across the value chain

The cumulative impact of U.S. tariffs and related trade dynamics in 2025 has reverberated through the canine supplement value chain, prompting strategic reassessment of sourcing, pricing, and inventory practices. Increased import duties and heightened customs scrutiny have elevated landed costs for certain ingredient categories and packaging components, which in turn has pressured gross margins and necessitated adjustments to commercial strategies. In response, many organizations undertook portfolio rationalization to prioritize higher-margin SKUs and to defer lower-performing SKUs while they evaluated sourcing alternatives.

As a result of these trade shifts, procurement teams accelerated supplier diversification efforts and explored nearshoring to mitigate exposure to tariff volatility and transit disruptions. This reorientation often required new supplier qualification protocols, heightened quality assurance oversight, and capital allocation to support dual-sourcing contracts and safety stock. Simultaneously, logistics teams re-engineered inbound flows to optimize for consolidated shipments, bonded warehousing, and improved customs classification to minimize duty liabilities.

Market-facing teams translated these operational adjustments into revised channel tactics. Retail pricing strategies were rebalanced to reflect increased cost bases while protecting core consumer segments through targeted promotions and subscription incentives. At the same time, the tariff environment strengthened the case for vertical integration for some manufacturers that could internalize critical processing steps to control input costs and quality. Cumulatively, the tariff-driven changes have accelerated structural shifts toward resilient supply chains, differentiated channel mixes, and sharper portfolio management.

In-depth segmentation synthesis revealing how form, ingredient chemistry, channel dynamics, life-stage targeting, and combination compositions determine commercial opportunity and operational priorities

Segment-level insights reveal where product, channel, and life-stage strategies intersect and where differentiation can create sustainable advantage. Based on Form, the market is studied across chewable, liquid, powder, and tablet formats; chewable formats further segment by popular flavors such as beef, chicken, and peanut butter, which influence palatability and repeat purchase among companion animals. Form choice impacts manufacturing complexity, shelf-life management, and claims architecture, with chewables often commanding premium positioning due to convenience and perceived treat-like attributes.

Based on Ingredient Type, the market is studied across hydrochloride, N acetyl, and sulfate variants; each form presents trade-offs in perceived efficacy, sourcing availability, and cost-to-formulate. Product teams must therefore match ingredient selection with clinical evidence, stability profiles, and regulatory considerations to craft clear comparative messaging. Based on Distribution Channel, the market is studied across mass merchant, online, pet specialty store, and veterinary pathways; within online distribution, nuance matters as manufacturer website commerce and third-party marketplace placements deliver different economics, data visibility, and brand control. This channel segmentation informs assortment decisions, promotional cadence, and service levels for subscription fulfillment.

Based on Dog Age, the market is studied across adult, puppy, and senior cohorts, reflecting differing needs for palatability, dosing frequency, and supportive adjuncts; senior dogs typically drive demand for joint support, but puppy formulations present opportunities for preventive positioning. Based on Composition, the market is studied across combination and single formulations; combination offerings are further analyzed across inclusion of chondroitin, hyaluronic acid, and MSM, which enable multi-mechanistic approaches to joint health and create avenues for differentiated claims and premium pricing. Integrating these segmentation lenses allows stakeholders to design targeted R&D, manufacturing, and marketing plans that align with consumer preferences and channel economics.

Comprehensive regional insights describing how the Americas, Europe Middle East & Africa, and Asia-Pacific each shape product, channel, and regulatory strategies for global expansion

Regional dynamics materially influence product strategy, channel choice, and regulatory planning, and a nuanced view of geographies is essential for international growth. In the Americas, consumer demand skews toward premiumization and evidence-based products, with strong penetration of online and mass merchant channels; this region typically emphasizes convenience, flavor variety, and clinical credentials, and it is often a proving ground for subscription and loyalty mechanics. Cross-border trade flows and regional regulatory frameworks further shape formulation choices and labeling practices.

In Europe, Middle East & Africa, regulatory diversity and heterogeneous retail structures require flexible market entry strategies, localized labeling, and sometimes reformulation to meet national standards. In this macro-region, specialty pet retailers and veterinary channels can be influential for premium and clinically oriented products, while e-commerce growth varies significantly across individual markets, demanding tailored digital strategies. Asia-Pacific presents a mosaic of opportunity driven by rapid pet ownership growth, rising discretionary spend on companion animals, and distinct preferences for formats and flavors; distribution here often involves hybrid models that combine traditional pet specialty channels with rapidly expanding online marketplaces. Understanding the regulatory regimes, consumer trust drivers, and distribution idiosyncrasies across these regions is vital for scaling product lines, negotiating trade terms, and sequencing market launches.

Key competitive intelligence focused on how formulation science, veterinary partnerships, and channel execution separate leaders from followers in canine joint supplement markets

Competitive dynamics in the canine glucosamine category center on the interplay between formulation differentiation, channel presence, and credibility with veterinary professionals. Leading firms pursue distinct paths: some emphasize premium, combination formulations supported by clinical trials and veterinarian endorsements, while others compete on value through higher-volume, lower-cost formats optimized for mass channels. Competitive positioning is also influenced by brand heritage and trust, with newer entrants leveraging digital-native marketing and subscription models to accelerate trial.

Partnerships with veterinary clinics and opinion leaders remain a decisive factor for market acceptance of novel formulations and claims, as veterinarians often act as trusted gatekeepers for pet health interventions. In parallel, retail-channel strategies-spanning mass merchant listings, pet specialty assortments, and curated manufacturer storefronts online-determine discoverability and repeat purchase economics. Manufacturing capacity, access to high-quality API suppliers, and the ability to maintain consistent product quality under heightened regulatory scrutiny differentiate firms operationally. Ultimately, companies that align scientific validation with robust channel execution and transparent ingredient sourcing are better positioned to convert consumer intent into sustained loyalty.

Practical and prioritized recommendations directing leaders to fortify formulation strategies, digital distribution, supplier resilience, and regulatory credibility for commercial advantage

Actionable recommendations for industry leaders focus on aligning product roadmaps, commercial models, and operational capabilities to current market realities. First, prioritize formulation strategies that balance evidence, palatability, and manufacturing feasibility; combination formulations that integrate complementary actives can command premium positioning when supported by clear mechanistic rationale and stability data. Second, accelerate digital-first distribution while preserving strategic relationships with pet specialty and veterinary channels; manufacturer-owned commerce should be used to capture first-party data and to test subscription and personalization initiatives, while third-party marketplaces can scale awareness and lower acquisition costs.

Third, strengthen sourcing resilience through supplier diversification and modular supply agreements that allow rapid shifts between ingredient forms such as hydrochloride, N acetyl, and sulfate variants without compromising product integrity. Fourth, invest in regulatory intelligence and label transparency to preempt compliance challenges across geographies and to earn trust with veterinarians and informed consumers. Finally, deploy segmented marketing tactics keyed to life-stage cohorts-adult, puppy, and senior-and to form preferences like chewable flavors and delivery format to improve conversion and lifetime value. Implementing these recommendations requires cross-functional roadmaps with clear owners, timelines, and success metrics to translate strategic intent into market impact.

Transparent explanation of the mixed-methods research approach combining primary interviews, product audits, secondary synthesis, and data triangulation to support actionable insights

The research methodology underpinning this analysis combines qualitative and quantitative techniques to ensure rigorous, actionable outputs. Primary research included in-depth interviews with supply-side stakeholders, formulation scientists, procurement leads, retail merchandisers, and veterinary professionals to capture firsthand perspectives on efficacy expectations, channel economics, and supplier capabilities. These interviews were complemented by product and packaging audits that assessed formulation claims, flavor assortments, and manufacturing attributes across representative SKUs.

Secondary research synthesized regulatory guidance documents, industry publications, and trade data to map tariff impacts, logistics trends, and trade compliance considerations. Data triangulation was applied to reconcile divergent inputs and to surface robust insights without relying on single-source assertions. Analytical techniques included segmentation cross-tabulation, channel profitability assessment, and scenario analysis to evaluate strategic options under different supply chain and trade conditions. To bolster transparency, methodological limitations and assumptions were documented, and key informant quotations were retained where appropriate to illustrate stakeholder sentiment. This mixed-methods approach enables confidence in the directional findings and the recommended strategic pathways.

Concise concluding synthesis emphasizing the necessity of integrating formulation credibility, resilient operations, and omnichannel execution to capture enduring value

In conclusion, the canine glucosamine supplement category is at an inflection point where product science, channel evolution, and trade dynamics jointly shape competitive advantage. Pet owners' expectations for efficacy, safety, and convenience are rising, and companies that can credibly demonstrate differentiated value-through combination formulations, clinical validation, and transparent sourcing-will capture disproportionate loyalty. Meanwhile, distribution strategies that integrate manufacturer-owned commerce with selective retail and veterinary partnerships will optimize acquisition and retention economics.

Operational resilience remains essential in a context marked by tariff-related cost pressure and supply chain complexity. Firms that proactively diversify suppliers, optimize inventory strategies, and strengthen customs and compliance capabilities will be better positioned to sustain margins and service levels. Ultimately, translating these insights into concrete outcomes requires disciplined prioritization, cross-functional execution, and continuous feedback loops between R&D, supply chain, and commercial teams. By aligning science-led product development with resilient operations and thoughtful channel strategy, organizations can convert market shifts into lasting advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Glucosamine Supplement for Dog Market, by Form

  • 8.1. Chewable
    • 8.1.1. Beef
    • 8.1.2. Chicken
    • 8.1.3. Peanut Butter
  • 8.2. Liquid
  • 8.3. Powder
  • 8.4. Tablet

9. Glucosamine Supplement for Dog Market, by Ingredient Type

  • 9.1. Hydrochloride
  • 9.2. N Acetyl
  • 9.3. Sulfate

10. Glucosamine Supplement for Dog Market, by Composition

  • 10.1. Combination
    • 10.1.1. Chondroitin
    • 10.1.2. Hyaluronic Acid
    • 10.1.3. Msm
  • 10.2. Single

11. Glucosamine Supplement for Dog Market, by Distribution Channel

  • 11.1. Mass Merchant
  • 11.2. Online
    • 11.2.1. Manufacturer Website
    • 11.2.2. Third Party Marketplace
  • 11.3. Pet Specialty Store
  • 11.4. Veterinary

12. Glucosamine Supplement for Dog Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Glucosamine Supplement for Dog Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Glucosamine Supplement for Dog Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Glucosamine Supplement for Dog Market

16. China Glucosamine Supplement for Dog Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ainsworth Pet Nutrition LLC
  • 17.6. All Living Things, Inc.
  • 17.7. Biovencer Healthcare Private Limited
  • 17.8. Elanco Animal Health Incorporated
  • 17.9. Nestle Purina PetCare Company
  • 17.10. Nutramax Laboratories, Inc.
  • 17.11. PetLab Co., Inc.
  • 17.12. TSI Group Ltd.
  • 17.13. VetIQ, LLC
  • 17.14. VetriScience Laboratories, Inc.
  • 17.15. VetsPlus USA, Inc.
  • 17.16. Zesty Paws IP, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY BEEF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY BEEF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY BEEF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHICKEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHICKEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHICKEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PEANUT BUTTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PEANUT BUTTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PEANUT BUTTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYDROCHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYDROCHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYDROCHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY N ACETYL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY N ACETYL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY N ACETYL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SULFATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SULFATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SULFATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHONDROITIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHONDROITIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHONDROITIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SINGLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SINGLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SINGLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MASS MERCHANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MASS MERCHANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MASS MERCHANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PET SPECIALTY STORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PET SPECIALTY STORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY PET SPECIALTY STORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 148. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 151. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 152. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GCC GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 172. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 175. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 176. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. G7 GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 180. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 183. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 184. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. NATO GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY CHEWABLE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY COMBINATION, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA GLUCOSAMINE SUPPLEMENT FOR DOG MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)